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Abstract  1 
Intestinal inflammation is a natural process crucial for the maintenance of gut functioning. 2 
However, abnormal or prolonged inflammatory responses may lead to the onset of chronic 3 
degenerative diseases, typically treated by means of pharmacological interventions. Dietary 4 
strategies for prevention of inflammation are a safer alternative to pharmacotherapy.  Anthocyanins 5 
and other polyphenols have been documented to display anti-inflammatory activity. In the present 6 
study, three bioactive fractions (anthocyanin, phenolic and water soluble fractions) were extracted 7 
from a wild blueberry powder. The Caco-2 intestinal model was used to test the immunomodulatory 8 
effect of the above fractions. Only the anthocyanin-rich fraction reduced in a dose-dependent 9 
manner the activation of NF-κB, induced by IL-1β in intestinal epithelial Caco-2 cells. Specifically, 10 
concentrations of 50 µg mL-1 and 100 µg mL-1 decreased NF-κB activation by 68.9% and 85.2%, 11 
respectively (p≤0.05). These preliminary results provide further support for the role of food 12 
bioactives as potential dietary anti-inflammatory agents.  13 
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Introduction 18 
Inflammation is a non-specific immune response consisting of complex reactions as the body 19 
defends itself against injuries that are encountered daily by host cells such as the mucosal surface of 20 
the gastrointestinal tract. The orchestration of these responses guarantees both effective protection 21 
against harmful agents and maintenance of homeostasis. The nuclear factor κB (NF-κB) pathway is 22 
an immunological route through which inflammation processes are triggered and regulated. The 23 
NF-κB transcription factor exists in an inactive state in the cytosol of cells; upon its activation and 24 
translocation into the nucleus the induction of genes involved in immune and pro-inflammatory 25 
responses is induced, leading to the expression of cytokines and chemokines, adhesion molecules 26 
and inflammatory enzymes.1 27 
In some individuals, or in particular conditions, the above system fails to suppress the inflammatory 28 
processes once activated, leading to exacerbated responses and to the onset of pathological 29 
consequences like intestinal bowel diseases (IBD). Usually, effective therapies are mainly based on 30 
pharmacological interventions, which are often connected with adverse side effects. Therefore, the 31 
potential of utilizing dietary strategies to prevent and/or reduce the inflammatory state may 32 
represent a safer and affordable tool.  33 
Polyphenols are a class of phytochemicals that have been shown to modulate inflammatory 34 
processes.2In vitro and in vivo studies report that pure polyphenolic molecules, but also plant 35 
extracts, can interfere with immunological pathways and the production of inflammatory 36 
mediators.3 37 
The anti-inflammatory abilities of polyphenols have been partially attributed to a direct action on 38 
the host immune system. It is reported that these bioactives could affect different intracellular 39 
pathways in the intestinal mucosa by triggering specific immune responses.4 In fact, diverse 40 
phenolic compounds (e.g. kaempferol, quercitin, genistein, luteolin) have been documented  to exert 41 
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their effects through the attenuation of pro-inflammatory cytokines.5,6 Consequently, it has been 42 
proposed that such compounds may decrease the risk of individuals to develop chronic 43 
inflammation.4 Specifically, previous investigations (both in in vitro and in mouse models) 44 
documented that polyphenols can exert modulatory effects in presence of different inflammatory 45 
stimuli.2 46 
ACNs are pigments of the polyphenol class that confer red to blue color to several common fruits 47 
and vegetables, which have been shown to exert different health-promoting properties as 48 
documented both in in vitro and in vivo studies.7-12Apart from their antioxidant activity13, ACNs  49 
play a key role in promoting host health through diverse mechanisms: from improvement of lipid 50 
profiles, vasomotor tone and blood pressure to the modulation of detoxifying enzymes7-10 and 51 
inflammation.11,12,14 52 
ACNs are poorly absorbed15, even if new evidence suggests higher bioavailability than previously 53 
reported16. Consequently most of them reach the colon where their concentrations, as well as that of 54 
other polyphenols, can reach high concentrations, justifying a beneficial effect against IBD.17  55 
Thus the present study aims to investigate the effect of different bioactive fractions, obtained from 56 
an ACN-rich Wild Blueberry (WB, Vaccinium angustifolium) powder, on immune responses in 57 
CaCo-2 cells following exposure to a pro-inflammatory stimulus. 58 
 59 
Materials and methods 60 
Chemicals and Materials - Standard of cyanidin (Cy)-, delphinidin (Dp)-, petunidin (Pt)-, peonidin 61 
(Pe)-, and malvidin (Mv)-3-O-glucoside (glc), Cy- and Pt-3-O-arabinoside (ara), Cy-3-O-62 
galactoside (gal), Dp, Cy, and Mv were purchased from Polyphenols Laboratory (Sandes, Norway). 63 
Eagle’s minimum essential medium (EMEM), Trypsin, fetal calf serum (FCS), D-luciferin, 64 
adenosine triphosphate (ATP), phosphate buffer saline (PBS), penicillium, streptomycin, non 65 
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essential amino acids, L-glutamine, HEPES, and Tris-HCl buffer, intereukin 1β and standards of 66 
chlorogenic, caffeic, ferulic, glucose, fructose, malic, citric acid were obtained from Sigma-Aldrich. 67 
Hydrochloric acid, methanol, acetonitrile, triethylamine, phosphoric acid, trifluoroacetic acid (TFA) 68 
and ethyl acetate were from Merck (Darmstadt, Germany). Water was obtained from Milli-Q 69 
apparatus (Millipore, Milford, MA). Zeocin and plasmid pNiFty2-Luc where purchased from 70 
Invivogen (Labogen, Rho, Italy). Freeze-dried Wild Blueberry (WB) powder, standardized at 1.5% 71 
total ACNs, was provided by Future-Ceuticals Company (Momence, IL, USA). 72 
 73 
Separation and chemical characterization of WB fractions 74 
Extraction of bioactives from the WB powder -The freeze-dried WB powder was used to extract 75 
three different fractions providing the main WB bioactives: the water soluble fraction (containing 76 
mainly sugars and organic acids - WS fraction), the ethyl acetate soluble fraction (containing 77 
mainly chlorogenic acid - Phe fraction) and the methanol soluble fraction (containing mainly 78 
anthocyanins - ACN fraction).  79 
Extraction was performed following the method described by Wrolstad18 with few modifications. 80 
Briefly, the WB powder was suspended in water, sonicated for 10 min, and centrifuged at 3000 × g 81 
for 10 min. Fraction separation from the supernatant was obtained through solid-phase extraction 82 
(SPE)-cartridge (Strata-X 300 mg/3 mL, Phenomenex, Torrence, CA). Three mL of supernatant was 83 
loaded and the elution of WS, Phe and ACN fractions were carried out respectively with HCl 0.01 84 
N (5 mL), ethyl acetate (10 mL) and methanol (5 mL) containing 0.1% HCl. The fractions were 85 
dried under vacuum with rotavapor (RC Jouan 10, Jouan, Winchester, VA) at 20 °C for ACN, 40 °C 86 
for Phe and up to 60 °C for the WS fraction. The residues were dissolved in methanol acidified with 87 
HCl (0.05 mM) for the ACNs, methanol for the Phe, and water for the WS fractions. The solutions 88 
were analyzed for the content of ACNs, Phe, sugars and organic acids, and stored at -20 °C until 89 
use. 90 
  
6 
 91 
Analysis of ACN and Phe-rich fractions -Analysis was performed with a liquid chromatographic 92 
system, which consisted of an Alliance mod. 2695 (Water, Milford, MA) equipped with a mod. 93 
2998 photodiode array detector (Waters). The separation was carried out through a C18 Kinetex 94 
column (150 x 4.6 mm, 2.6 µm, Phenomenex, Torrence, CA) at 45 °C and 1.7 mL min-1 as flow 95 
rate. The eluents were (A) 1% H3PO4 and (B) acetonitrile/water (35:65, v/v). The elution gradient 96 
was linear as indicated: 0-15 min 14% B; 15-25 min from 14 to 20% B; 25-35 min from 20 to 32% 97 
B; 35-45 min from 32 to 50% B; 45-48 min from 50 to 90% B; 90% for 3 min. Chromatographic 98 
data were acquired from 200 to 700 nm and integrated at 520 (ACNs) and 320 nm (Phe). 99 
Calibration curves ranged from 2 to 50 µg mL-1 were obtained for cyanidin (Cy-), delphinidin (Dp-100 
), petunidin (Pt-), peonidin (Pe-) and malvidin (Mv-) 3-O-glc, Cy- and Pt-3-O-gal and Pt-3-O-ara 101 
and chlorogenic acid. For the ACNs, the working solution was diluted from the stock solution with 102 
methanol acidified with 0.1% TFA. Each analysis was carried out in duplicate. The identification of 103 
single ACNs was confirmed by LC coupled to ESI-MS (electro spray ionization - mass 104 
spectrometry) as already described by Del Bo’et al.9 Briefly, the mass spectrometer operated in 105 
positive full-scan mode in the range 200-800 Da. The capillary voltage was set to 3.5 kV, the cone 106 
voltage to 20 V, the source temperature to 130 °C, and the desolvating temperature to 350 °C. Data 107 
were acquired by Masslinx 4.0 software (Micromass, Beverly, MA). 108 
 109 
Analysis of sugars - Glucose and fructose were quantified in WB fractions by UPLC (Acquity, 110 
Waters) coupled with a triple quadrupole mass spectrometer mod. Quattro micro (Micromass, 111 
Beverly, MA). 112 
The separation was carried out on BEH (Ethylene Bridged Hybrid) Amide column (150 x 2.1 mm, 113 
1.7 µm, Waters) at 35 °C. Solvents were (A) triethylamine 0.2% and (B) triethylamine 0.2% in 114 
acetonitrile. Flow-rate was 0.40 mL min-1. The calibration curve was obtained from 1 to 50 µg mL-1 115 
  
7 
for both sugars. The mass spectrometer operated in ESI negative mode monitoring the ions with m/z 116 
179 (glucose, fructose). The capillary voltage was set to 3.0 kV, the cone voltage to 20 V, the 117 
source temperature to 120 °C, and the desolvating temperature to 250 °C.   118 
Analysis of organic acids - Malic and citric acids were analyzed by UPLC (Acquity, Waters) 119 
coupled to a triple quadrupole mass spectrometer mod. Quattro micro (Micromass, Beverly, MA). 120 
The separation was performed on C18 Atlantis T3 column (150 x 2.1 mm, 1.7 µm, Waters) at 45 °C 121 
and the flow rate was 0.5 mL min-1. The eluent was formic acid 0.05%. The calibration curves were 122 
obtained over the concentration range 2 to 25 µg mL-1 for both malic and citric acid. The capillary 123 
voltage was set to 3.5 kV, the cone voltage and the collision energy was specific for each 124 
compound. The source temperature was 120 °C, the desolvating temperature was 300 °C and argon 125 
was used at 1.3x10-3 mbar to improve fragmentation in the collision cell. Masslinx 4.0 acquired data 126 
with Quan-Optimize option for fragmentation study. The fragmentation transitions for the multiple 127 
reaction monitoring (MRM) were (m/z)- 133115, 13371 for malic and (m/z)- 191111, 128 
19187 for citric acid, with a dwell time of 0.2 s per transition. 129 
 130 
Immunomodulatory activity of ACN-rich fraction evaluated on Caco-2 cell line 131 
In vitro cultivation - Caco-2 cells (human epithelial colorectal adenocarcinoma cell line; ATCC 132 
HTB-37) is a well-established and validated model of the human intestinal barrier.19 They were 133 
routinely grown in Eagle’s minimum essential medium (EMEM) supplemented with 10% (v/v) 134 
heat-inactivated (30 min at 56 °C) fetal calf serum (FCS), 100 U mL-1 penicillin, 100 µg mL-1 135 
streptomycin, 0.1 mM nonessential amino acids (NEAA), and 2 mM L-glutamine and were 136 
incubated at 37 °C in a water-jacketed incubator in an atmosphere of 95% air and 5% carbon 137 
dioxide.  138 
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Study of NF-κB activation. Stable recombinant Caco-2 cell line was generated by transfecting cells 139 
with the plasmid pNiFty2-Luc as described by Guglielmettiet al.20. This plasmid contains a 140 
promoter with five NF-B-binding sites followed by the firefly luciferase reporter gene luc. Stimuli 141 
that activate NF-B promote its binding to the vector promoter, resulting in the expression of the 142 
luciferase gene. Briefly, Caco-2 were transfected by means of the StoS transfection kit (GeneSpin, 143 
Milan, Italy), in accordance with the manufacturer’s protocol. Afterwards, cells were resuspended 144 
in fresh EMEM, seeded in 24-well plates, and incubated for 48 h, in order to obtain the expression 145 
of the antibiotic resistance. Finally, stable recombinant clones were selected by adding into the 146 
culture medium 50 µg mL-1 of zeocin. 147 
Stimulation protocol and NF-κB-luciferase assay -After growth in the presence of 50 µg mL-1 148 
zeocin, differentiated cell monolayers (approximately 3×105 cells well-1) were carefully washed 149 
with 0.1 M Tris-HCl buffer (pH 8.0). Subsequently, fresh EMEM medium, containing 100 mM 150 
HEPES (pH 7.4) was added to Caco-2 cells. The WS, Phe and ACN-rich fractions obtained by WB 151 
powder have been tested. Concentrations used were 25, 50 and 100 μg mL-1 for the WS fraction 152 
(calculated considering the sugars and organic acid concentration), and 5, 25, 50 and 100 μg mL-1 153 
for the Phe-rich fraction (calculated considering the chlorogenic acid concentration) and the ACN-154 
rich fraction (calculated considering the total ACNs concentration). Only minor changes of pH were 155 
registered (pH 7.6± 0.1) when supplementing cells with extract doses corresponding to the highest 156 
concentration. Recombinant Caco-2 cells were simultaneously stimulated with interleukin-1β (IL-157 
1β, 2 ng mL-1), used as pro-inflammatory stimulus. After incubation at 37 °C for 4 h, 24-well plates 158 
were put on ice for 15 min; recombinant Caco-2 cells were detached mechanically from the bottom 159 
of a well, samples were transferred into an eppendorf tube and subjected to sonication at maximum 160 
power for 5 s using a Bandelin SONOPLUS Ultrasonic Homogenizer (Bandelin electronic GmbH 161 
& Co., Berlin, Germany). Insoluble particles were removed by centrifugation and the supernatants 162 
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were transferred into a new tube. One hundred μL of supernatants were aliquoted in duplicate into 163 
the wells of a 96-well white microtiter plate (PerkinElmer, Monza, Italy) by means of epMotion 164 
Automated Pipetting System (Eppendorf, Milan, Italy). Then 12.5 μL of a 10 mM ATP solution 165 
(i.e. up to the final concentration of 1 mM) and 12.5 μL of 0.1 mM D-luciferin solution were added, 166 
and the emitted bioluminescence was immediately measured every 120 s with a VICTOR3 1420 167 
Multilabel Counter (PerkinElmer). The maximum of light production curve was considered for 168 
comparison of results. All conditions were analyzed in duplicate in eight independent experiments. 169 
Cell viability assay- The methosulfate (MTS) test is a spectrophotometric method used to evaluate 170 
vitality and number of living cells.21 The test was performed on cells treated with ACN-rich fraction 171 
(5, 25, 50 and 100 g mL-1), with media (Control 1), and media added with MetOH + 0.05 mM HCl 172 
(Control 2. After incubation at 37 °C for 4 h, the medium was removed from Caco-2 cells, and the 173 
cells were carefully washed with 500 μL of PBS. Trypsin (Trypsin 0.25%, 2.5 g porcine trypsin + 174 
0.2 g EDTA) was added to lyse cells. EMEM medium, containing 100 mM HEPES (pH 7.4) was 175 
added and 100μL of supernatant was aliquoted into a 96-well microtiter plate (PerkinElmer, Monza, 176 
Italy) by means of epMotion Automated Pipetting System and 10μL of MTS was added. The plate 177 
was incubated at 37 °C for 90 min and the absorbance of MTS at 490 nm was measured by a 178 
spectrophotometer (Biorad, UK). 179 
Statistical analysis 180 
Statistical analysis was performed by means of STATISTICA software (Statsoft Inc., Tulsa, OK, 181 
US). Analysis of variance (ANOVA), with type of treatment as the dependent factor, was used to 182 
evaluate the immunomodulatory activity of the different WB fractions on Caco-2 cells. The same 183 
analysis was performed to ensure cell viability following the ACN-rich fraction supplementation. 184 
Post-hoc analysis of differences between treatments was assessed by the Least Significant 185 
Difference (LSD) test with p ≤ 0.05 as level of statistical significance. 186 
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Results 187 
Characterization of Wild blueberry (WB) fractions 188 
The three fractions obtained from the WB powder were analyzed  to evaluate the content of sugars 189 
and organic acids, phenols and ACNs. The water soluble fraction (WS)  contained 4.12 g mL-1 of 190 
sugars, corresponding to 2.28 ± 0.12 g mL-1 and 1.84 ± 0.13 g mL-1 of glucose and fructose, 191 
respectively. The content of malic acid and citric acid was 19.9 ± 2.10 g mL-1 and 47.2 ± 4.23 g 192 
mL-1,respectively. Conversely the content of ACNs and phenols was negligible. Sugars and organic 193 
acids were detected only in the WS fraction. 194 
In the Phe-rich fraction, throughout chlorogenic acid was the main phenolic compound (719.2 ± 195 
21.4 g mL-1), with  traces of caffeic and ferulic acids. No ACNs, sugars or organic acids were 196 
detected. 197 
The ACN-rich fraction composition is reported in Table 1. The total ACN content was 1563 ± 102 198 
g mL-1. Fourteen different ACNs were detected in the fraction; the dominant compounds were: Mv 199 
glycosides (about 540 g mL-1; 35% of the total ACN amount) and Dp glycosides (about 492 g 200 
mL-1; 31%) followed by Cy glycosides (about 293 g mL-1; 19%), while Pt and Pe glycosides 201 
represented about 11% and 4.2% of the total ACNs, respectively. The rank order for conjugated 202 
sugars was glucoside>galactoside>arabinoside from the most to the least representative (Table 1). 203 
No phenolic compounds, sugars and organic acids, were detected. 204 
 205 
Modulation of NF-κB activation by WS, Phe and ACN-rich fractions in Caco-2 cells 206 
To identify the class of potential bioactive molecules provided by our WB powder, we tested the 207 
effects of the three different fractions isolated from WB (i.e. WS, Phe, ACN-rich) on NF-κB 208 
pathway activation. Experiments on Caco-2 cells were performed in the presence of the pro-209 
inflammatory stimulus IL-1β. No significant differences in light emission levels were observed 210 
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following Phe and WS exposure, and none of the Phe or the WS concentrations used (up to 100 g 211 
mL-1) resulted in a significant reduction in the NF-κB induction level compared to control. On the 212 
contrary, the ACN-rich fraction was able to reduce significantly NF-κB activation (Figure 1). In 213 
particular, the bioluminescence, and therefore NF-κB activation, was reduced by 68.9% and 85.2% 214 
at the concentration of 50 and 100 μg mL-1 respectively (p≤0.05). 215 
 216 
Cell viability 217 
No significant difference in cell viability was observed following Caco-2 cell supplementation. 218 
Thus, the reduction of NF-κB activation observed was not ascribable to a cytotoxic effect of high 219 
concentrations of the ACN-rich fraction (Table 2).  220 
 221 
Discussion 222 
Prolonged inflammation mediated by NF-κB activation may contribute to the pathogenesis of 223 
chronic diseases such as inflammatory bowel disease, diabetes, neurodegenerative diseases, cancer, 224 
and cardiovascular diseases.3,22,23 In particular the regulation of NF-κB activation at the epithelial 225 
interfaces, such as  at gut level, is of particular importance for the maintenance of mucosal integrity, 226 
barrier function and homeostasis. Excessive activation of NF-κB at the gut level has been associated 227 
with inflammatory bowel disease.24 228 
NF-κB is the main target in several anti-inflammatory therapies (e.g. non-steroidal anti-229 
inflammatory drugs)25,26 that are not specific for NF-κB inhibition and are required in relatively 230 
high concentrations leading to problems of adverse side effects and toxicity.26 231 
The use of natural bioactive molecules, like polyphenols, which possess the ability to attenuate NF-232 
κB activation, might represent a safer and effective strategy in repressing inflammatory processes. 233 
Several studies suggest that blueberry polyphenols display anti-inflammatory effects that are not 234 
specifically related to their antioxidant properties.27ACNs, flavonols and phenolic acids could be the 235 
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phytochemicals mainly responsible for this activity. Thus, in our study, we extracted and 236 
characterized three fractions (WS, Phe and ACN-rich fraction) from the freeze dried WB powder in 237 
order to investigate the potential anti-inflammatory ability exerted by the different bioactive-rich 238 
fractions. The ACN profile of the WB used in the current research differs from that of previous 239 
studies both in qualitative and quantitative composition.28,29 Generally, Mv, Dp, Cy, Pt, Pe 240 
glycosides are the most abundant ACNs found in wild blueberry.9,30,31  In the ACN-rich fraction 241 
prepared for this study that originated from wild blueberry (Vaccinium angustifolium), the dominant 242 
compounds were Mv glycosides (35% of the total ACN amount), Dp glycosides (31%) and Cy 243 
glycosides (19%). On the contrary, Yi et al.28 using three different blueberry cultivars (Briteblue, 244 
Tifblue, and Powderblue) reported higher level of Pt and Pe glycosides in the ACN fraction, 245 
whereas Triebel et al.29 detected  higher level of Dp glycosides and Cy glycosides from bilberry 246 
(Vaccinium myrtillus L.). These differences may be explained considering that ACN profile of 247 
blueberry can vary between different cultivars and growing conditions32; finally the extraction 248 
procedures may affect molecule recovery. However, it is noteworthy that ACN absorption and their 249 
anti-proliferative effects were demonstrated to be comparable in Caco-2 cell monolayers 250 
supplemented with different ACN fractions obtained from several blueberry cultivars.31Moreover, 251 
the authors reported that ACN absorption and average transport efficiency in the Caco-2 cell model 252 
was comparable to that evidenced in in vivo studies (i.e. about 3-4%).33 253 
Concerning the Phe-rich fraction, chlorogenic acid was the main compound detected. Traces of 254 
hydroxycinnamic acids, such as caffeic and ferulic acids, were also found. These results disagree 255 
with findings by Yi et al.28 in which gallic, caffeic, p-coumaric and ferulic acids were identified in 256 
three different cultivars. The differences may be due to the blueberry cultivar investigated as well as 257 
to the freeze-drying process which may contribute to the decrease in phenols. 258 
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Finally, the immunomodulatory effect of the WS fraction was investigated to ascertain the potential 259 
contribution of sugars (i.e. glucose and fructose) and organic acids (i.e. malic acid and citric acid), 260 
not included in the ACN and Phe-rich fractions.  261 
The WS fraction did not show any immunomodulatory potential, even though some studies 262 
suggest an induction of the NF-kB pathway following supplementation with sugars34. Similarly, no 263 
significant effect was observed following Phe-rich fraction exposure. These results are in contrast 264 
with other studies which documented an anti-inflammatory and inhibitory activity of phenolic 265 
compounds on NF-κB.5,6,35 In particular, Rodriguez-Ramiro et al.36 documented  that a cocoa 266 
polyphenolic extract (10 µg mL-1) decreased the nuclear levels of NF-kB and the expression of 267 
several cytokines in the colon of rats. Additionally, the authors confirmed in Caco-2 cells that the 268 
cocoa polyphenol-rich extract, downregulated the levels of inflammatory markers by inhibiting NF-269 
κB activation. The capacity of polyphenols to downregulate the NF-κB signaling pathway was also 270 
observed by Romier et al.37 in a Caco-2 intestinal model upon supplementation with different 271 
polyphenols (50 µmol L-1). Moreover, Kim et al.38 reported that the ﬂavonoid luteolin (50 µmol L-1) 272 
prevented lipopolysaccharide-induced NF-κB signaling and gene expression by blocking IκB kinase 273 
activity in intestinal epithelial cells. These conflicting results could be attributed to the different 274 
type and amount of polyphenols used, and the specific role played by each single phenolic 275 
compound. 276 
In the present study, only the ACN–rich fraction tested revealed an immunomodulatory 277 
potential on transfected human intestinal epithelial Caco-2 cells. 278 
In particular, a significant decrease of NF-κB activation was observed at ACN-rich fraction 279 
concentrations of 50 and 100 µg mL-1.Our results are in agreement with others demonstrating the 280 
ability of ACNs in the modulation of NF-κB, and down-stream signalling in vitro in different cell 281 
models.3,39-41 For example, supplementation with ACN-rich extract (100 µg mL-1) isolated from 282 
bilberries and blackcurrants modulated in vitro LPS-induced activation of NF-κB in monocytes.3 283 
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Kim et al.42 showed that the administration of a soybean seed coat extract (providing from 1 to 100 284 
µg mL-1 ACNs) significantly inhibited NF-κB activation in endothelial cells.  285 
Beneficial effects were also observed in vivo with ACN-rich foods. For example, the use of a wild-286 
blueberry-enriched diet in Zucker rats was able to downregulate the expression of NF-κB, both in 287 
the liver and the abdominal adipose tissue, and to reduce several circulating inflammatory markers 288 
as CRP, IL-6 and TNF-α.14 Moreover, interestingly, in a parallel-design controlled clinical trial, the 289 
supplementation of healthy subjects with ACNs from blueberry (Medox, 300 mg d-1 for 3 weeks) 290 
reduced the levels of circulating NF-κB-dependent inflammatory mediators such as IL-8 and IFN-291 
α.3 292 
In the present in vitro study, the use of extracts instead of single ACNs is limited since it does not 293 
reveal the effect of single bioactive compounds on the NF-κB pathway.  In this regard, the ACN-294 
rich fraction was further characterized for the content of vitamin A and E43, ascorbic acid44, 295 
carotenoids43, fatty acids45, fiber46 and minerals eventually recovered during the extract preparation. 296 
None of the compounds were detectable apart from traces of fatty acids (palmitic, stearic, oleic and 297 
linoleic acids). Concerning minerals, only traces of magnesium, phosphorus and manganese were 298 
present, while calcium, sodium and zinc were the main compounds found. However, Caco-2 cell 299 
supplementation with the ACN-rich fraction provided less than 1.1 µg mL-1 of the above minerals.  300 
In addition we cannot exclude that other bioactive compounds not identified in the ACN-rich 301 
fraction could have contributed to the anti-inflammatory effect observed. In fact, some of them 302 
might interact synergistically or additively with ACNs or other bioactives. In this regard, the 303 
contribution of ACN metabolites such as protocatechuic acid, whose concentration in vivo is 304 
reported to be much higher than the parent compound47,48 cannot be ruled out. The extensive 305 
activity of the gut microbiota in the colon may also be another contributory factor.49 306 
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Additionally, it is known from cell culture studies, that under simulated physiological conditions 307 
(pH and temperature) a significant rate of degradation of ACNs occurs with formation of isoforms 308 
(e.g. chalcone, hemiketal) and phenolic acids that can contribute to the effects observed.50,51 Finally 309 
a possible limitation of cell culture studies where food extracts are used, is the omission of the step 310 
simulating gastrointestinal digestive processes as it happens in vivo. 311 
In conclusion, our preliminary results show that the ACN-rich fraction extracted from the 312 
WB powder displayed anti-inflammatory properties by decreasing the activation of NF-κB in 313 
presence of the pro-inflammatory stimulus IL-1β. This ability might be particularly useful in the 314 
prevention/control of several inflammatory disorders, like IBD, as already observed in mouse 315 
model.49 316 
Further investigations are necessary to identify the individual components and/or 317 
metabolites of the ACN-rich fraction responsible of this immunomodulatory ability. Future research 318 
should target the identification of  potential functional components that could aid in the 319 
development of innovative strategies preventing chronic inflammatory diseases without the side 320 
effects of pharmacotherapy. 321 
322 
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FIGURE CAPTIONS 489 
Figure 1 490 
Modulation of light emission expressed by Caco-2 cells transfected with a NF-κB/luciferase 491 
reporter vector and incubated in presence of interleukin-1β with the ACN-rich fraction. Data are 492 
reported as percent variation of light emission, referred to the control. Control: Caco-2 cell layers 493 
incubated only with media supplemented with MetOH + 0.05 mM HCl. ACNs: anthocyanin-rich 494 
fraction. ACN concentrations (5-25-50-100) are referred to µg mL-1. The values are the means (+ 495 
standard deviations) for eight independent experiments conducted in duplicate. Asterisks indicate 496 
statistically significant differences compared to results for the control (*, P<0.05) 497 
 498 
 499 
 500 
 501 
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Table 1: Characterization of the ACN-rich Fraction 
Compounds 
Extracted 
g mL-1 % 
malvidin 3-glca 
malvidin 3-galb 
malvidin 3-arac 
delphinidin 3-glca 
delphinidin 3-galb 
delphinidin 3-arac 
251 ± 6.3 
224 ± 8.1 
65.1 ± 4.1 
224 ± 17.2 
166 ± 13.1 
102 ± 9.8 
16.4 
14.3 
4.2 
14.3 
10.6 
6.5 
cyanidin 3-glca 
cyanidin 3-galb 
cyanidin 3-arac 
99.1 ± 8.6 
69.1 ± 3.4 
124 ± 9.9 
6.3 
4.4 
7.8 
petunidin 3-glca 
petunidin 3-galb 
43.2 ± 2.3 
107 ± 11.1 
2.8 
6.8 
petunidin 3-arac 
peonidin 3-glca 
peonidin 3-galb 
22.1 ± 3.7 
28.2 ± 2.2 
38.2 ± 2.1 
1.4 
1.8 
2.4 
Total 1563 ± 102 100 
 
Data are reported as mean±standard deviation. 
a=glc, glucoside; b=gal, galactoside; c=ara, arabinoside  
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Table 2: MTS Viability Test. Data Are Reported as a Measure of Absorbance at 490 nm. Caco-2 
Cell Layers Incubated with ACN-rich Fraction (5, 25, 50, 100 g mL-1) only with Media (Control 
1) and Media with MetOH + 0.05 mM HCl (Control 2). ACNs: Anthocyanin-rich Fraction. The 
Values Are Expressed as Percentage Mean (± Standard Deviations) for two Independent 
Experiments. 
 
Cell viability % 
Control 1 100 
Control 2 74.5 ± 18.3 
ACNs 5 µg mL-1 77.4 ± 14.9 
ACNs 10 µg mL-1 73.3 ± 18.9 
ACNs 50 µg mL-1 65.7 ± 25.1 
ACNs 100 µg mL-1 90.1 ± 10.2 
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